6505--GLP1A Glucagon-like Peptide 1 Receptor Agonists
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 36E79720R0055
- Agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation seeks proposals for a one-year contract, with four one-year option periods, to supply once-weekly glucagon-like peptide-1 receptor agonists (GLP1 agonists) with FDA approval to reduce cardiovascular risk in adults with type 2 diabetes. The Department of Veterans Affairs National Acquisition Center intends to issue RFP 36E79720R0055 to supply these drugs to the VA, Bureau of Prisons, and Indian Health Service. Offerors must propose pricing for two GLP1 agonists in specified package configurations and quantities totaling approximately 920,000 units annually. Proposals are due by July 2, 2020 and will be evaluated without using a set-aside.
The NAICS code is 325412. There is no set-aside designation. The estimated annual requirement is for 920,000 packages of two GLP1 agonists (dulaglutide and semaglutide) across four strength configurations to be distributed through the VA pharmaceutical prime vendor program to VA, BOP, and IHS facilities nationwide over the one-year base period and four one-year option periods. Questions are due by June 26, 2020 and can be directed to the point of contact listed in the notice.
Notice text
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0055 for an unrestrictive procurement for once-weekly Glucagon-like peptide-1 receptor agonists (GLP1 agonist) with an FDA approved indication to reduce risk of major cardiovascular outcomes in adults with type 2 diabetes for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA Pharmaceutical Prime Vendor Program. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79720R0055 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about June 17, 2020, with a tentative closing date of July 2, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Teresa Hussain. Questions can be e-mailed to: Teresa.Hussain@va.gov.
The estimated annual requirements are as follows:
Item Description Size Estimated Annual Requirements
1a
DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN 4 PACK
OR
1
383,700
1b
SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML 1 PACK
AND
2a
DULAGLUTIDE 1.5MG/0.5ML INJ,SOLN,PEN 4 PACK
OR
1
536,592
2b
SEMAGLUTIDE 1MG/0.75ML INJ,SOLN,PEN,1.5ML 2 PACK
Files
| File | Type | Posted |
|---|---|---|
| 36E79720R0055 0002.docx | DOCX document | |
| 36E79720R0055 0001.docx | DOCX document | |
| 36E79720R0055.docx | DOCX document |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 6505--Semaglutide (Ozempic) Inj Soln - GLP1A Glucagon-like Peptide 1 Receptor Agonists | Award Notice | |
| This notice | Solicitation | |
| 6505--GLP1A Glucagon-like Peptide 1 Receptor Agonists | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity